openPR Logo
Press release

Endometrial Cancer Treatment Market Segments 2024-2033 | Size, Share And Insights

04-29-2024 05:57 AM CET | Health & Medicine

Press release from: The Business research company

Endometrial Cancer Treatment Market

Endometrial Cancer Treatment Market

The endometrial cancer treatment market size has grown strongly in recent years. It will grow from $29.9 billion in 2023 to $31.41 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to demographic trends, advancements in diagnostic tools, treatment guidelines and protocols, awareness and screening programs, evolution of healthcare infrastructure.

The endometrial cancer treatment market size is expected to see strong growth in the next few years. It will grow to $38.96 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rising incidence of endometrial cancer, personalized medicine approaches, immunotherapy advancements, expanding targeted therapies, government initiatives and funding. Major trends in the forecast period include development of hormone therapies, implementation of artificial intelligence (ai) in treatment planning, exploration of novel chemotherapeutic agents, enhanced supportive care, clinical trials for emerging therapies.

Market Overview -
Endometrial cancer treatment refers to the medical interventions aimed at managing and potentially curing cancer that develops in the lining of the uterus.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10735&type=smp

Rising Prevalence Of Endometrial Cancer Through Advances In The Endometrial Cancer Treatment Market
The growing prevalence of endometrial cancer is expected to propel the growth of the endometrial cancer treatment market going forward. The prevalence of endometrial cancer refers to an increase in the number of cases of endometrial cancer within a specific population or over a certain period. This shift has resulted from changes in risk factors, improved detection and diagnosis methods, increased awareness, and an aging population. Endometrial cancer treatments help in early endometrial cancer detection, providing targeted therapies, prevention of recurrence, and clinical trials and research studies to improve treatment options. As the prevalence of endometrial cancer continues to rise and advancements in treatment options expand, the endometrial cancer treatment market is expected to grow. For instance, in 2023, according to Cancer.Net, a website that provides oncologist-approved cancer information, an estimated 66,200 people in the United States will be diagnosed with uterine, or endometrial cancer. Therefore, the rise in prevalence of endometrial cancer is driving the growth of the endometrial cancer treatment market.

Competitive Landscape -
Major companies operating in the endometrial cancer treatment market report are Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Siemens Healthcare AG, Merck & Co. Inc., Sanofi-Aventis, Ariad Pharmaceuticals Inc., Becton Dickinson And Company, Teva Pharmaceutical Industries Limited, AstraZeneca plc, Pfizer Inc., Bristol-Myers Squibb Company, Celgene Corp., Eisai Co. Ltd., AbbVie Inc., Roche Holding AG, Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Bayer AG, Eli Lilly and Company, Varian Medical Systems Inc., Regeneron Pharmaceuticals Inc., Seattle Genetics Inc., Spectrum Pharmaceuticals Inc., Stemline Therapeutics Inc., Syros Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Novocure Ltd.

Roche's Ventana Mmr Rxdx Panel Redefines Endometrial Cancer Diagnosis And Treatment Landscape
Technological advancements in endometrial cancer diagnosis and treatment are a key trend gaining popularity in the endometrial cancer treatment market. Companies operating in the market are launching technologically advanced endometrial cancer diagnoses and treatments to sustain their position in the market. For instance, in April 2022, Roche Holding AG received FDA approval for VENTANA MMR RxDx Panel endometrial cancer diagnostic kit to diagnose patients eligible for anti-PD1 immunotherapy that is treatment with JEMPERLI (dostarlimab-gxly) monotherapy. This test is an effective tool for clinicians for patient diagnosis and providing new treatment options to women having MMR-deficient endometrial cancer during or after chemotherapy treatment.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/endometrial-cancer-treatment-global-market-report

Key Segments -

The endometrial cancer treatment market covered in this report is segmented -

1) By Type: Adenocarcinoma, Uterine Carcinosarcoma, Squamous Cell Carcinoma, Small Cell Carcinoma, Transitional Carcinoma, Serous Carcinoma, Other Types
2) By Diagnosis Method: Biopsy, Pelvic Ultrasound, Hysteroscopy, CT Scan, Other Diagnosis Methods
3) By Route Of Administration: Oral, Intravenous
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Key highlights covered in the report -

1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endometrial Cancer Treatment Market Segments 2024-2033 | Size, Share And Insights here

News-ID: 3478267 • Views:

More Releases from The Business research company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Strategy Insights
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Company Registration Service Market Through 2025? The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025? In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market in 2025: Advancement In Digital Insurance Platforms Transforms Small And Medium Enterprises Coverage With Integrated, Data-Driven Solutions
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025? The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due To Rising Environmental Monitoring Requirements: Strengthening the Growth Trajectory of the Combustion Emissions Analyzer Market
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025? In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Endometrial

Rising Prevalence Of Endometrial Cancer Through Advances In The Endometrial Canc …
The Endometrial Cancer Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Endometrial Cancer Treatment Market Size and Projected Growth Rate? The Endometrial Cancer Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to
Advanced Endometrial Cancer Pipeline: A Spotlight on the Most Promising Developm …
The Advanced Endometrial Cancer Pipeline Insight 2023 report by DelveInsight offers a thorough global overview of Advanced Endometrial Cancer treatments, including those already in the market, as well as those in different phases of clinical development. Prominent pharmaceutical firms are dedicated to progressing the Advanced Endometrial Cancer pipeline landscape and fostering the potential growth of Advanced Endometrial Cancer therapeutic advancements. Key Takeaways from the Advanced Endometrial Cancer Pipeline Report • DelveInsight's Advanced
Endometrial Biopsy Cannulae Market 2023
The report presents detailed information regarding the prominent players and potential competitors in the Endometrial Biopsy Cannulae market. It includes comprehensive insights into their worldwide presence, economic performance, strategies, upcoming product releases, research and development initiatives, and a SWOT analysis. Additionally, the report analyses revenue share and contact details for each player. This comprehensive report aims to evaluate and forecast the market size for Fuel Monitoring Systems. It analyses revenue, growth
Hysteroscopic Endometrial Resection Market - Transforming Hysteroscopy, Enhancin …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Hysteroscopic Endometrial Resection Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Hysteroscopic Endometrial Resection provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes
Endometrial Ablation Market snapshot 2024
Global Endometrial Ablation Market: Snapshot With the rising prevalence of gynecology disorders, such as polycystic ovarian disease (PCOD), abnormal vaginal bleeding, the global adoption of endometrial ablation procedures has increased significantly, leading to an impressive rise in the worldwide endometrial ablation market. Apart from this, the upswing in the incidence rate of cervical and endometrial cancer in women is also driving the growth of this market substantially across the world. Download The
Global Endometrial Ablation Market: Radiofrequency Endometrial Ablation Devices …
With the presence of large players, such as Hologic Corp., Boston Scientific Corp., Cooper Surgical Inc., Ethicon Inc., and Medtronic Plc at the global level, the worldwide market for endometrial ablation demonstrates a highly competitive landscape, finds a new research report by Transparency Market Research (TMR). The market players are focusing aggressively on developing their offerings technologically, which is likely to lead to price differentiation, resulting in intense rivalry between these